价格

peptides (obesity)

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ACYLATED GLUCAGON ANALOGUES
EP 3057984 B1申请人: ZEALAND PHARMA AS优先权: 2013
CN
EP
US
WO
18 件公开
LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE
EP 4352088 A4申请人: SCRIPPS RESEARCH INST优先权: 2021
CN
EP
US
WO
8 件公开
IL-4 DERIVED PEPTIDES FOR USE IN THE TREATMENT OF OBESITY
EP 4591930 A3申请人: SERODUS APS优先权: 2022
CN
EP
US
WO
7 件公开
Glucagon analogues
- US 8541368 B2
  申请人: NOVO NORDISK AS优先权: 2012
  US
  6 件公开
- US 2015111817 A1
  申请人: ZEALAND PHARMA AS优先权: 2013
  CN
  US
  4 件公开
- US 9180169 B2
  申请人: ZEALAND PHARMA AS优先权: 2013
  US
  4 件公开
- US 7994122 B2
  申请人: ZEALAND PHARMA AS优先权: 2008
  US
  2 件公开
CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
EP 4781998 A2申请人: CORTERIA PHARMACEUTICALS优先权: 2022
EP
US
WO
5 件公开
USE OF LONG-ACTING GLP-1 PEPTIDES
EP 3689365 B1申请人: NOVO NORDISK AS优先权: 2012
EP
US
5 件公开
CYCLIC CHEMERIN-9 DERIVATIVES
EP 4196143 A1申请人: BAYER AG优先权: 2020
CN
EP
US
WO
4 件公开
COMPOSITIONS COMPRISING OCTADECANEUROPEPTIDES (ODN) AND SYNTHETIC DERIVATIVES THEREOF AND METHODS OF USE FOR MODULATION OF FOOD INTAKE, OBESITY, BODY WEIGHT, NAUSEA, AND EMESIS
EP 4618957 A1申请人: UNIV PENNSYLVANIA优先权: 2022
CN
EP
US
WO
4 件公开
Melanocortin receptor agonists
US 7517854 B2申请人: NOVO NORDISK AS优先权: 2003
CN
US
4 件公开
Glucagon/GLP-1 agonists for the treatment of obesity
US 9765130 B2申请人: MEDIMMUNE LTD优先权: 2012
CN
US
4 件公开

药物

peptides (obesity)

专利

Glucagon analogues